KEITA

This brand name is authorized in Nigeria.

Active ingredients

The drug KEITA contains one active pharmaceutical ingredient (API):

1
UNII O18YUO0I83 - KETAMINE HYDROCHLORIDE
 

Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist into the recovery period.

 
Read more about Ketamine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
C4-1983 Solution for injection Keita Injection INJ_SOL 500 mg/10 mL 1 X 10VIALS Solution for injection in a labelled vial containing ketamine anaesthetics. 26/05/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N01AX03 Ketamine N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database C4-1983

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.